Novel SA-53 MDM2 Inhibitor Therapy Has Potential to be a Breakthrough in Genetically Targeted Cancer Treatment (CLEVELAND, OH) – Steady progress for Lamassu Biotech’s potentially transformative cancer treatment. The private, pioneering...
Category: news
Hahn will Bring Unparalleled Experience in Drug Development to Growing Biotech Firm (CLEVELAND, OH) – Stephen Hahn, MD, 24th Commissioner of Food and Drugs and the former chief medical executive...
03/25/2026
Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs
Study could transform care for a leading cause of hospitalizations in pets and people (COLUMBUS, OH) - Acute pancreatitis is a painful, life-threatening condition that affects an estimated 1.8 million...